These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6206836)

  • 1. Histopathology of focally photocoagulated preretinal new vessels.
    Wallow IH; Skuta GL
    Arch Ophthalmol; 1984 Sep; 102(9):1340-4. PubMed ID: 6206836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choroidovitreal neovascular ingrowth after photocoagulation for proliferative diabetic retinopathy.
    Chandra SR; Bresnick GH; Davis MD; Miller SA; Myers F
    Arch Ophthalmol; 1980 Sep; 98(9):1593-9. PubMed ID: 6158936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenon arc photocoagulation of proliferative diabetic retinopathy. A review of 2688 consecutive eyes in the format of the Diabetic Retinopathy Study.
    Okun E; Johnston GP; Boniuk I; Arribas NP; Escoffery RF; Grand MG
    Ophthalmology; 1984 Dec; 91(12):1458-63. PubMed ID: 6084216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
    Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
    Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.
    Plumb AP; Swan AV; Chignell AH; Shilling JS
    Br J Ophthalmol; 1982 Apr; 66(4):213-8. PubMed ID: 6175340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 1. Effect on disc vessels, visual fields, and visual acuity.
    Hamilton AM; Townsend C; Khoury D; Gould E; Blach RK
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):87-92. PubMed ID: 6192562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic correlation of xenon arc and argon laser photocoagulation. Procedure in human diabetic eyes.
    Wallow IH; Davis MD
    Arch Ophthalmol; 1979 Dec; 97(12):2308-15. PubMed ID: 574760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.
    Birch J; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):93-9. PubMed ID: 6192563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy.
    Meyers SM
    Am J Ophthalmol; 1980 Aug; 90(2):210-6. PubMed ID: 6158867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photocoagulation for optic disc new vessels in diabetes mellitus.
    Asher R; Hunt S; Hamilton AM; Townsend C; Blach RK; Khoury D; Kohner EM; Morris DV
    Int Ophthalmol; 1981 Mar; 3(2):79-85. PubMed ID: 6164659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative electroretinograms in argon laser and xenon arc panretinal photocoagulation.
    Liang JC; Fishman GA; Huamonte FU; Anderson RJ
    Br J Ophthalmol; 1983 Aug; 67(8):520-5. PubMed ID: 6683566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1981 Jul; 88(7):583-600. PubMed ID: 7196564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. I. Preliminary results.
    Jampol LM; Condon P; Farber M; Rabb M; Ford S; Serjeant G
    Ophthalmology; 1983 May; 90(5):540-5. PubMed ID: 6192381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
    Blankenship GW
    Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiments on the absorption of argon and krypton laser by blood.
    Folk JC; Shortt SG; Kleiber PD
    Ophthalmology; 1985 Jan; 92(1):100-8. PubMed ID: 2579360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on choroidal nerves after panretinal xenon arc and argon laser photocoagulation.
    Schiødte SN
    Acta Ophthalmol (Copenh); 1984 Apr; 62(2):244-55. PubMed ID: 6720291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden severe visual loss associated with peripapillary burns during panretinal argon photocoagulation.
    Swartz M; Apple DJ; Creel D
    Br J Ophthalmol; 1983 Aug; 67(8):517-9. PubMed ID: 6683565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ophthalmoscopic and fluorographic aspects of diabetic retinopathy before and after argon laser photocoagulation].
    Verougstraete C; Toussaint D
    Bull Soc Belge Ophtalmol; 1980; (188-189):137-56. PubMed ID: 6166341
    [No Abstract]   [Full Text] [Related]  

  • 19. [Focal epiretinal fibroplasias overlying photocoagulations in diabetic retinopathy (author's transl)].
    Daicker BC
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1980; 214(2):71-82. PubMed ID: 6906167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group.
    Am J Ophthalmol; 1976 Apr; 81(4):383-96. PubMed ID: 944535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.